EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Network Organization, Null-Model Assessment, and Robustness of a Published Mycobacterium tuberculosis Candidate Drug-Resistance Gene Panel

Mehmet Burhan Küçükoğlu, Gözde Öztan, Halim İşsever, Ayşe Emel Önal, Uğurcan Sayılı

International Journal of Molecular Sciences · 20.11.2026 · 27 (22) · 10454

DOI: 10.3390/ijms272210454 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 20.11.2026. Verfasst von Mehmet Burhan Küçükoğlu und 4 weiteren Autor:innen. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Drug-resistant tuberculosis remains a major challenge, but resistance-associated genes are commonly interpreted as separate drug-specific lists. We reorganized a previously published TBProfiler Tier 1/Tier 2 candidate-gene panel into a reproducible bipartite network and quantified connected components, bipartite density, centrality, Jaccard similarity, the Szymkiewicz–Simpson overlap coefficient, evidence-tier sensitivity, degree-preserving null expectations, and leave-one-edge/gene-out robustness. The full network contained 14 drug/drug-class nodes, 49 genes, 71 edges, six disconnected components, and a bipartite density of 0.1035. In the full network, rrs had the highest number (four) of linked drugs, whereas Rv1258c had the highest full-network betweenness (0.203) but fell to zero in the Tier 1-only network. In 10,000 degree-preserving randomizations, however, Rv1258c betweenness did not exceed the null expectation (empirical p = 0.205), indicating that this ranking is compatible with the panel’s degree structure. Pairwise drug similarity, as expressed by the Jaccard coefficient, highlighted bedaquiline-clofazimine (0.833), amikacin-capreomycin (0.625), amikacin-kanamycin (0.429), and isoniazid-ethionamide (0.300); corresponding Szymkiewicz–Simpson overlap coefficients were 1.000, 0.833, 1.000, and 0.500, respectively. In the primary analysis encompassing all 91 drug-pair comparisons, three overlaps—bedaquiline–clofazimine, amikacin–capreomycin, and amikacin–kanamycin—exceeded degree-preserving null expectations after BH-FDR correction (q = 0.0046, 0.0046, and 0.0243, respectively). The separate analysis restricted to the 12 pairs with non-zero observed Jaccard similarity was considered exploratory and did not inform the primary conclusions. The amikacin–capreomycin Jaccard value fell to 0.250 under Tier 1 restriction, showing dependence on Tier 2 assignments. Collapsing amikacin, kanamycin, and capreomycin into a single second-line-injectable node preserved six components and broadly retained gene-centrality ranks (Spearman’s rank correlation coefficient, ρ= 0.851). Published CRyPTIC co-resistance patterns remained concordant with the bedaquiline–clofazimine and amikacin–kanamycin overlaps. The framework therefore quantifies the organization, evidence-tier dependence, and robustness of existing candidate-resistance associations; it does not establish novel resistance mechanisms, diagnostic accuracy, or patient-level clinical predictions.

Zitieren

APA

Küçükoğlu, M. B., Öztan, G., İşsever, H., Önal, A. E., & Sayılı, U. (2026). Network Organization, Null-Model Assessment, and Robustness of a Published Mycobacterium tuberculosis Candidate Drug-Resistance Gene Panel. International Journal of Molecular Sciences, 27(22), 10454. https://doi.org/10.3390/ijms272210454

Vancouver

Küçükoğlu MB, Öztan G, İşsever H, Önal AE, Sayılı U. Network Organization, Null-Model Assessment, and Robustness of a Published Mycobacterium tuberculosis Candidate Drug-Resistance Gene Panel. International Journal of Molecular Sciences. 2026;27(22):10454. doi:10.3390/ijms272210454

BibTeX
@article{Kkolu2026,
  author = {Küçükoğlu, Mehmet Burhan and Öztan, Gözde and İşsever, Halim and Önal, Ayşe Emel and Sayılı, Uğurcan},
  title = {Network Organization, Null-Model Assessment, and Robustness of a Published Mycobacterium tuberculosis Candidate Drug-Resistance Gene Panel},
  journal = {International Journal of Molecular Sciences},
  year = {2026},
  volume = {27},
  number = {22},
  pages = {10454},
  doi = {10.3390/ijms272210454}
}
Kostenlos starten →